Probability of Phase II success for new drugs in select disease areas in the U.S. between 2006 and 2015
U.S. drug development Phase II success rates 2006-2015, by disease area
This statistic shows the probability of Phase II success for new drugs in the U.S., within the period from January 1, 2006 to December 31, 2015, by disease area. It was found that drugs in hematology had the highest Phase II success rates.
Probability of Phase II success for new drugs in select disease areas in the U.S. between 2006 and 2015
Phase II success rate
Hematology57%
Metabolic45%
Ophthalmology45%
Infectious disease43%
Endocrine40%
Gastroenterology*36%
Urology33%
Allergy33%
Autoimmune32%
All indications31%
Neurology30%
Respiratory29%
Oncology25%
Cardiovascular24%
Psychiatry24%
Other40%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
U.S. drug development Phase II success rates 2006-2015, by disease area
This statistic shows the probability of Phase II success for new drugs in the U.S., within the period from January 1, 2006 to December 31, 2015, by disease area. It was found that drugs in hematology had the highest Phase II success rates.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Clinical trials
Clinical trials

All Information
in one Presentation

Clinical trials

Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Clinical trials"
  • R&D overview
  • Top R&D companies
  • Clinical studies
  • Participation
  • Costs and market
  • Success rates
The most important statistics
  • Approvals, launches, setbacks
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.